JP2017012144A5 - - Google Patents

Download PDF

Info

Publication number
JP2017012144A5
JP2017012144A5 JP2015200708A JP2015200708A JP2017012144A5 JP 2017012144 A5 JP2017012144 A5 JP 2017012144A5 JP 2015200708 A JP2015200708 A JP 2015200708A JP 2015200708 A JP2015200708 A JP 2015200708A JP 2017012144 A5 JP2017012144 A5 JP 2017012144A5
Authority
JP
Japan
Prior art keywords
vitamin
composition according
citrulline
active ingredients
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015200708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017012144A (ja
JP6584270B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015200708A priority Critical patent/JP6584270B2/ja
Priority claimed from JP2015200708A external-priority patent/JP6584270B2/ja
Publication of JP2017012144A publication Critical patent/JP2017012144A/ja
Publication of JP2017012144A5 publication Critical patent/JP2017012144A5/ja
Application granted granted Critical
Publication of JP6584270B2 publication Critical patent/JP6584270B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015200708A 2015-10-09 2015-10-09 血流改善組成物 Active JP6584270B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015200708A JP6584270B2 (ja) 2015-10-09 2015-10-09 血流改善組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015200708A JP6584270B2 (ja) 2015-10-09 2015-10-09 血流改善組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015133936A Division JP5888574B1 (ja) 2015-07-02 2015-07-02 血流改善剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019158789A Division JP6838752B2 (ja) 2019-08-30 2019-08-30 血流改善組成物

Publications (3)

Publication Number Publication Date
JP2017012144A JP2017012144A (ja) 2017-01-19
JP2017012144A5 true JP2017012144A5 (enExample) 2019-03-14
JP6584270B2 JP6584270B2 (ja) 2019-10-02

Family

ID=57827326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015200708A Active JP6584270B2 (ja) 2015-10-09 2015-10-09 血流改善組成物

Country Status (1)

Country Link
JP (1) JP6584270B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2685324B1 (es) * 2017-03-30 2019-07-22 Phidinut S L Composición farmacéutica o complemento nutricional para la prevención y/o el tratamiento del ojo seco
JP6484774B1 (ja) * 2017-11-30 2019-03-20 株式会社東洋新薬 経口用組成物
WO2019117702A1 (en) * 2017-12-16 2019-06-20 Kam Faii Yuen A medicament to control and reduce hypertension
JP6484776B1 (ja) * 2018-06-26 2019-03-20 株式会社東洋新薬 経口用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008253148A (ja) * 2007-03-30 2008-10-23 Naris Cosmetics Co Ltd 冷え性改善機能を有する食品組成物
JP2009067731A (ja) * 2007-09-14 2009-04-02 Office K:Kk 冷え性改善用組成物
JP5921143B2 (ja) * 2011-10-27 2016-05-24 株式会社ヤクルト本社 ショウガ含有飲料の風味改善剤
JP2013237629A (ja) * 2012-05-14 2013-11-28 Oriza Yuka Kk 末梢血行害改善剤
JP6064156B2 (ja) * 2012-07-10 2017-01-25 株式会社東洋新薬 深部体温上昇剤

Similar Documents

Publication Publication Date Title
TN2018000368A1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof.
PH12018500284A1 (en) 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
MY161088A (en) Agonists of gpr40
MX2019003363A (es) Composiciones farmaceuticas para usarse en la terapia de la blefaritis.
MX2020002271A (es) Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
JP2017012144A5 (enExample)
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
BR112015029773A2 (pt) pós revestidos com aroma
JP2017014155A5 (enExample)
PH12017500159B1 (en) [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases
WO2015001541A3 (en) Pharmaceutical film composition
JP2016210757A5 (enExample)
JP2017008001A5 (enExample)
WO2016178510A3 (ko) 진세노사이드 Ｆ1 또는 Ｒｇ3를 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
JP2017007966A5 (enExample)
JP2017014164A5 (enExample)
JP2016216373A5 (enExample)
HUE070960T2 (hu) Ketoprofén kokristálya és elõállítási módja, ketoprofén kokristályát tartalmazó gyógyszerészeti készítmények, valamint felhasználási céljaik
MX2022006741A (es) Formas de estado solido del inhibidor de hdac.
JP2017002009A5 (enExample)
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
JP2017001966A5 (enExample)
JP2017008002A5 (enExample)
WO2013112873A3 (en) Compositions and methods for improving lactation